111 related articles for article (PubMed ID: 8357203)
1. An in vitro model for disease-specific immunotherapy in myasthenia gravis using soluble MHC class II bound to AChR-derived peptide.
Nicolle MW; Vincent A; Sharma S; Nag B; Willcox N; Newsom-Davis J
Ann N Y Acad Sci; 1993 Jun; 681():577-80. PubMed ID: 8357203
[No Abstract] [Full Text] [Related]
2. Immune response gene control of lymphocyte proliferation induced by acetylcholine receptor-specific helper factor derived from lymphocytes of myasthenic mice.
Christadoss P; Lindstrom JM; Talal N; Duvic CR; Kalantri A; Shenoy M
J Immunol; 1986 Sep; 137(6):1845-9. PubMed ID: 2943805
[TBL] [Abstract][Full Text] [Related]
3. Anti-nicotinic receptor autoimmunity in myasthenia gravis. Establishment of specific T-helper cell lines and identification of sensitizing epitopes on the alpha-subunit.
Hohlfeld R; Toyka K; Heininger K; Tzartos SJ; Walgrave SL; Protti P; Conti-Tronconi BM
Monogr Allergy; 1988; 25():50-67. PubMed ID: 2459613
[No Abstract] [Full Text] [Related]
4. T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis.
Moiola L; Protti MP; Manfredi AA; Yuen MH; Howard JF; Conti-Tronconi BM
Ann N Y Acad Sci; 1993 Jun; 681():198-218. PubMed ID: 7689306
[TBL] [Abstract][Full Text] [Related]
5. Acetylcholine receptor-specific human T-lymphocyte lines.
Hohlfeld R; Toyka KV; Michels M; Heininger K; Conti-Tronconi B; Tzartos SJ
Ann N Y Acad Sci; 1987; 505():27-38. PubMed ID: 2446551
[No Abstract] [Full Text] [Related]
6. Stimulation of autoimmune helper T lymphocytes from patients with myasthenia gravis with synthetic peptides of the acetylcholine receptor alpha subunit.
Hohlfeld R; Toyka KV; Miner LL; Conti-Tronconi BM
Ann N Y Acad Sci; 1988; 540():511-2. PubMed ID: 2462826
[No Abstract] [Full Text] [Related]
7. Complementary strategies to elucidate T helper cell epitopes in myasthenia gravis.
Jung C; Stoeckle C; Wiesmüller KH; Laub R; Emmrich F; Jung G; Melms A
J Neuroimmunol; 2008 Sep; 201-202():41-9. PubMed ID: 18649950
[TBL] [Abstract][Full Text] [Related]
8. Immunodominant regions for T helper-cell sensitization on the human nicotinic receptor alpha subunit in myasthenia gravis.
Protti MP; Manfredi AA; Straub C; Howard JF; Conti-Tronconi BM
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7792-6. PubMed ID: 2145582
[TBL] [Abstract][Full Text] [Related]
9. Myasthenia gravis: recognition of a human autoantigen at the molecular level.
Protti MP; Manfredi AA; Horton RM; Bellone M; Conti-Tronconi BM
Immunol Today; 1993 Jul; 14(7):363-8. PubMed ID: 8363727
[TBL] [Abstract][Full Text] [Related]
10. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis.
Yoshikawa H; Lambert EH; Walser-Kuntz DR; Yasukawa Y; McCormick DJ; Lennon VA
J Immunol; 1997 Aug; 159(3):1570-7. PubMed ID: 9233656
[TBL] [Abstract][Full Text] [Related]
11. Human acetylcholine receptor presentation in myasthenia gravis. DR restriction of autoimmune T epitopes and binding of synthetic receptor sequences to DR molecules.
Manfredi AA; Yuen MH; Moiola L; Protti MP; Conti-Tronconi BM
J Immunol; 1994 Apr; 152(8):4165-74. PubMed ID: 7511671
[TBL] [Abstract][Full Text] [Related]
12. Presentation of endogenous acetylcholine receptor epitope by an MHC class II-transfected human muscle cell line to a specific CD4+ T cell clone from a myasthenia gravis patient.
Baggi F; Nicolle M; Vincent A; Matsuo H; Willcox N; Newsom-Davis J
J Neuroimmunol; 1993 Jul; 46(1-2):57-65. PubMed ID: 7689595
[TBL] [Abstract][Full Text] [Related]
13. CD4+ T-epitope repertoire on the human acetylcholine receptor alpha subunit in severe myasthenia gravis: a study with synthetic peptides.
Manfredi AA; Protti MP; Wu XD; Howard JF; Conti-Tronconi BM
Neurology; 1992 May; 42(5):1092-100. PubMed ID: 1374548
[TBL] [Abstract][Full Text] [Related]
14. Analysis of helper T-cell specificity involved in the antibody response to the acetylcholine receptor.
Tami JA; Krolick KA
Ann N Y Acad Sci; 1988; 540():340-2. PubMed ID: 2462808
[No Abstract] [Full Text] [Related]
15. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance.
Christadoss P; Shenoy M; Oshima M; Atassi MZ
Adv Exp Med Biol; 1994; 347():65-75. PubMed ID: 7976734
[No Abstract] [Full Text] [Related]
16. Myasthenia gravis. T epitopes on the delta subunit of human muscle acetylcholine receptor.
Protti MP; Manfredi AA; Wu XD; Moiola L; Howard JF; Conti-Tronconi BM
J Immunol; 1991 Apr; 146(7):2253-61. PubMed ID: 1706391
[TBL] [Abstract][Full Text] [Related]
17. The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor.
Bellone M; Ostlie N; Lei SJ; Wu XD; Conti-Tronconi BM
J Immunol; 1991 Sep; 147(5):1484-91. PubMed ID: 1715360
[TBL] [Abstract][Full Text] [Related]
18. 'Split tolerance' induction by intrathymic injection of acetylcholine receptor in a rat model of autoimmune myasthenia gravis; implications for the design of specific immunotherapies.
Ohtsuru I; Matsuo H; Fukudome T; Suenaga A; Tsujihata M; Nagataki S
Clin Exp Immunol; 1995 Dec; 102(3):462-7. PubMed ID: 8536358
[TBL] [Abstract][Full Text] [Related]
19. Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes.
Nicolle MW; Nag B; Sharma SD; Willcox N; Vincent A; Ferguson DJ; Newsom-Davis J
J Clin Invest; 1994 Apr; 93(4):1361-9. PubMed ID: 7512979
[TBL] [Abstract][Full Text] [Related]
20. [Myasthenia gravis].
Kawaguchi N; Hattori T
Nihon Rinsho; 2005 May; 63 Suppl 5():416-21. PubMed ID: 15954385
[No Abstract] [Full Text] [Related]
[Next] [New Search]
